Table 2. Demographic and liver function tests of PKBA patients.

Parameter	All patients (n = 33)	25-OHVD < 23 (n = 23)	25-OHVD ≥ 23 (n = 10)	p-value
Age (years)	12.0 (5.5–18.5)	12.0 (5.0–16.0)	12.0 (5.0–19.0)	0.814
Male, No. (%)	12 (36.4)	7 (30.4)	5 (50)	0.433
Weight for age				0.054
5–15%	2	2 (8.7%)	0 (0)
15–50%	7	2 (8.7%)	5 (50%)
50–85%	15	11 (47.8%)	4 (40%)
85–97%	9	8 (34.8%)	1 (10%)
AST (U/L)	48 (28.5–94.5)	64 (34.5–132.75)	29 (21–46)	0.033
ALT (U/L)	78 (30–123.5)	98 (39.25–202)	32 (17–92)	0.063
Total bilirubin (mg/dL)	0.7 (0–1.45)	1.4 (1.1–1.9)	0.7 (0.7–0.7)	0.259
Direct bilirubin (mg/dL)	0.3 (0.2–0.9)	0.3 (0.2–0.9)	0.1 (0.1–0.1)	0.166
r-GT (IU/L)	103 (50–207)	121.5 (71.75–235)	64 (31–124.5)	0.139

Data are expressed as median (interquartile range) or number (percentage).

Abbreviations: 25-OHVD: 25-hydroxyvitamin D; ALT: alanine transaminase; AST: aspartate transaminase; PKBA: post Kasai’s portoenterostomy biliary atresia; rGT: gamma glutamyl transferase